Published Papers

  • The Effects of Active Hexose Correlated Compound (AHCC) on Levels of CD4+ and CD8+ in Patients with Epithelial Ovarian Cancer or Peritoneal Cancer Receiving Platinum Based Chemotherapy
    Wineeya Suknikhom, Ruangsak Lertkhachonsuk, Tarinee Manchana (Chulalongkorn University, Thailand)
    Asian Pacific Journal of Cancer Prevention, 18(3): 633-638 (2017)
  • Evaluation of Active Hexose Correlated Compound (AHCC) in Combination With Anticancer Hormones in Orthotopic Breast Cancer Models
    Judith A. Smith (UTHealth-Memorial Hermann Cancer Center, USA), et al.
    Integrative Cancer Therapies, DOI: 10.1177/1534735417704948 (2017)
  • Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis
    Sergi Segarra (Bioiberica S.A.U., Spain), Jose Ceron (University of Murcia, Spain), et al.
    Veterinary Parasitology, 239: 50-56 (2017)
  • Long-term administration of Active Hexose Correlated Compound as a dietary supplement to a patient after breast cancer surgery and chemotherapy: A case report
    Koji Wakame, Ken-ichi Komatsu (Hokkaido Pharmaceutical University School of Pharmacy, Japan), et al.
    Integrative Cancer Science and Therapeutics, 4(1): DOI: 10.15761/ICST.1000226 (2017)
  • DNA microarray analysis of gene expression changes in ICR mouse liver following treatment with active hexose correlated compound
    Koji Wakame, Ken-ichi Komatsu (Hokkaido Pharmaceutical University School of Pharmacy, Japan), et al.
    Integrative Molecular Medicine, 3(3): 739-744 (2016)
  • Protective effects of active hexose correlated compound in a rat model of liver injury after hepatectomy
    Richi Nakatake, Masanori Kon (Kansai Medical University, Japan), et al.
    Functional Foods in Health and Disease, 6(11): 702-717 (2016)
  • Active hexose correlated compound modulates LPS-induced hypotension and gut injury in rats
    Marie-Francoise Doursout, Anil Kulkarni (The University of Texas Medical School at Houston, USA), et al.
    International Immunopharmacology, 5(39): 280-286 (2016)
  • Polysaccharide from Lentinus edodes for Integrative Cancer Treatment: Immunomodulatory Effects on Lymphocyte Population
    Massimo Bonucci (Integrative Oncology, Casa di Cura San Feliciano, Italy), et al.
    World Cancer Research Journal, 3(1): e652 (2016)
  • Alleviating effect of Active Hexose Correlated Compound (AHCC) on chemotherapy-related adverse events in patients with unresectable pancreatic ductal adenocarcinoma
    Hiroaki Yanagimoto (Kansai Medical University, Japan), et al.
    Nutrition and Cancer, 68(2): 234-240 (2016)
  • Attenuation of Pulmonary Mycobacterium Avium Disease by Active Hexose Correlated Compound (AHCC) in Mice
    Masaki Fujita, Kentaro Watanabe (Fukuoka University, Japan), et al.
    Nutritional Disorders & Therapy, 5(4) (2015)
  • AHCC Activation and Selection of Human Lymphocytes via Genotypic and Phenotypic Changes to an Adherent Cell Type: A Possible Novel Mechanism of T Cell Activation
    Loretta Olamigoke, Alamelu Sundaresan (Texas Southern University, USA), et al.
    Evidence-Based Complementary and Alternative Medicine, Article ID 508746 (2015)
  • Active Hexose Correlated Compound and T Cell Response in Hind - Limb - Unloaded BALB/c Mice
    Mari Kogiso, Anil D. Kulkarni (The University of Texas Health Science Center and GSBS at Houston, USA), et al.
    International Journal of Surgery and Research, 2(5): 32-38 (2015)
  • Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells
    Masayuki Tokunaga, Yasuhiro Kuramitsu, et al. (Yamaguchi University Graduate School of Medicine, Japan)
    Anticancer Research, 35(11), 6063-6067 (2015)
  • Therapeutic effect of Active Hexose-Correlated Compound (AHCC) combined with CpG-ODN (oligodeoxynucleotide) in B16 melanoma murine model
    Rosa Mistica Ignacio, Soo-Ki Kim (Yonsei University, Korea), et al.
    Cytokine, 76(2): 131-137 (2015)
  • Active Hexose Correlated Compound Activates Immune Function to Decrease Chlamydia trachomatis Shedding in a Murine Stress Model
    Tesfaye Belay, Chuh-lung, Anthony Woart (Bluefield State College, USA)
    Journal of Nutritional Medicine and Diet Care, 1, 1 (2015)
  • Evaluation of active hexose correlated compound (AHCC) on phase II drug metabolism pathways and the implications for supplement-drug interactions
    Larry Coffer., Judith A. Smith (The University of Texas M.D. Anderson Cancer Center, USA), et al.
    Journal of Integrative Oncology, DOI:10.4172/2329-6771.1000142 (2015)
  • Active hexose correlated compound potentiates the antitumor effects of low-dose 5-fluorouracil through modulation of immune function in hepatoma 22 tumor-being mice
    Zhiyun Cao, Lianming Liao (Fujian University of traditional Chinese Medicine, China), et al.
    Nutrition Research and Practice, 9(2): 129-136, (2015)
  • Active Hexose Correlated Compound (AHCC) promotes an intestinal immune response in BALB/c mice and in primary intestinal epithelial cell culture involving toll-like receptors TLR-2 and TLR-4
    J.-F. Mallet, Barry W. Ritz, Chantal Matar (University of Ottawa, Canada), et al.
    European Journal of Nutrition, DOI 10.1007/s00394-015-0832-2 (2015)
  • Effects of Active Hexose Correlated Compound on the Seasonal Variations of Immune Competence in Healthy Subjects
    Jun Takanari, Takahiro Maeda (Amino Up Chemical Co, Ltd, Japan), et al.
    Journal of Evidence-Based Complementary & Alternative Medicine, 20(1): 28-34 (2015)
  • Effect of Active Hexose Correlated Compound (AHCC) in alcoholic fatty liver patients Jung-Ha Kima (Chung-Ang University College of Medicine, Korea), Jee-Aee Im (Sports and Medicine Research Center, Korea)
    Journal of Nutritional Science and Vitaminology, 60(5): 348-356 (2014)
  • Active Hexose-correlated Compound Down-regulates Sex-determining Region Y-box 2 of Pancreatic Cancer Cells
    Junya Nawata, Kazuyuki Nakamura (Yamaguchi University Graduate School of Medicine, Japan), et al.
    Anticancer Research, 34(9): 4807-4811 (2014)
  • Active hexose correlated compound exerts therapeutic effects in lymphocyte driven colitis
    Cristina Mascaraque, Olga Martinez-Augustin (University of Granada, Spain), et al.
    Molecular Nutrition & Food Research, 58(12): 2379-2382 (2014)
  • Adenosine, a hepato-protective component in active hexose correlated compound: Its identification and iNOS suppression mechanism
    Yoshito Tanaka, A-Hon Kwon (Kansai Medical University, Osaka, Japan), et al.
    Nitric Oxide, 40(31): 75-86 (2014)
  • Reduction of Adverse Effects by a Mushroom Product, Active Hexose Correlated Compound (AHCC) in Patients With Advanced Cancer During Chemotherapy-The Significance of the Levels of HHV-6 DNA in Saliva as a Surrogate Biomarker During Chemotherapy
    Toshinori Ito, Hatsumi Honda (Osaka University Graduate School of Medicine, Japan), et al.
    Nutrition and Cancer, 66(3): 377-382 (2014)
  • Active Hexose-correlated Compound Down-regulates HSP27 of Pancreatic Cancer Cells, and Helps the Cytotoxic Effect of Gemcitabine
    Shigeyuki Suenaga, Kazuyuki Nakamura (Yamaguchi University Graduate School of Medicine, Japan), et al.
    Anticancer Research, 34: 141-146 (2014)
  • Reactive Oxygen Species Mediate Disruption of Endothelial Adherens Junction Induced by Invasive Breast Cancer Cells (a mechanism that is attenuated by Active Hexose Correlated Compound, AHCC).
    Mehran Haidari (The University of Texas Health Science Center at Houston), et al.
    Life Science, 93(25-26): 994-1003 (2013)
  • An Evidence-Based Systematic Review of Active Hexose Correlated Compound (AHCC) by the Natural Standard Research Collaboration
    Catherine Ulbricht, Regina C. Windsor (Natural Standard Research Collaboration, USA), et al.
    Journal of Dietary Supplements, 10(3): 264-308 (2013)
  • Effect of Active Hexose-Correlated Compound in Women Receiving Adjuvant Chemotherapy for Breast Cancer: A Retrospective Study
    Sho Hangai, Satoru Iwase (The University of Tokyo Hospital, Japan), et al.
    The Journal of Alternative and Complementary Medicine, 19(11): 905-910 (2013)
  • A natural immune modulator attenuates stress hormone and catecholamine concentrations in polymicrobial peritonitis
    Katie M. Love, William G. Cheadle (School of Medicine, University of Louisville, USA), et al.
    The Journal of Trauma and Acute Care Surgery, 74(6): 1411-1418 (2013)
  • Active Hexose Correlated Compound Extends the Lifespan and Increases the Thermotolerance of Nematodes
    Tetsuya Okuyama, Mikio Nishizawa (Ritsumeikan University, Japan), et al.
    Functional Foods in Health and Disease, 3(6):166-182 (2013)
  • Short-term supplementation with Active Hexose Correlated Compound (AHCC) improves the antibody response to influenza B vaccine
    Brooke E. Roman, Elizabeth M. Gardner, et al. (Michigan State University, USA)
    Nutrition Research, 33(1): 12-17 (2013)
  • The nutritional supplement Active Hexose Correlated Compound (AHCC) has direct immunomodulatory actions on intestinal epithelial cells and macrophages involving TLR/MyD88 and NF-κB/MAPK activation
    Olga Martinez-Augustin (University of Granada, Spain), et al.
    Food Chemistry, 136(3-4): 1288-1295 (2013)
  • Stabilization of human interferon-α1 mRNA by its antisense RNA
    Tominori Kimura, Tadayoshi Okumura (Ritsumeikan University, Japan), et al.
    Cellular and Molecular Life Sciences, 70(8): 1451-1467 (2012)
  • Active Hexose Correlated Compound (AHCC) Alleviates Gemcitabine-Induced Hematological Toxicity in Non-Tumor-Bearing Mice
    Daisuke Nakamoto, Hiroshi Nishioka, et al. (Amino Up Chemical Co., Ltd., Japan)
    International Journal of Clinical Medicine, 3: 361-367 (2012)
  • Active hexose-correlated compound and Bifidobacterium longum BB536 exert symbiotic effects in experimental colitis
    Olga Martinez-Augustin, et al. (University of Granada, Spain)
    European Journal of Nutrition, 52(2): 457-466 (2013)
  • Personalized Cancer Therapy for Stage IV Lung Cancer: Combined Use of Active Hexose Correlated Compound and Genistein Concentrated Polysaccharide
    Reiki Ishizuka, Kuniyoshi Tajima (Tajima Clinic, Japan), et al.
    Personalized Medicine Universe, 1(1), 39-44, 2012
  • Active Hexose Correlated Compound promotes T helper (Th) 17 and 1 cell responses via inducing IL-1β production from monocytes in humans
    Won-Woo Lee, Insoo Kang, et al. (Yale University School of Medicine, USA)
    Cellular Immunology, 275(1-2), 19-23, 2012
  • Immunoprophylactic Effect of Active Hexose Correlated Compound on Normal and Induced Submandibular Salivary Gland Neoplasm in Albino Rats
    Tamer A. Badawi, Zouba H. Aly, et al. (Faculty of Oral and Dental Medicine, Cairo Unicersity, Egypt)
    Cairo Dental Journal, 28(1), 485-490, 2012
  • Active Hexose Correlated Compound Inhibits the Expression of Proinflammatory Biomarker iNOS in Hepatocytes
    Tadayoshi Okumura, A-Hon Kwon (Kansai Medical University, Japan), et al.
    European Surgical Research, 47, 274-283, 2011
  • AHCC: basic and clinical research
    Yasuo Kamiyama (Tokushima Tokusyuukai Hospital)
    Journal of the Society of Tropical Resources Technologists, 27(1): 1-8 (2011)
  • An Evidence-Based Review of a Lentinula edodes Mushroom Extract as Complementary Therapy in the Surgical Oncology Patient
    Shinil K. Shah, Anil D. Kulkarni, Richard J. Andrassy (University of Texas Medical School at Houston), et al.
    Journal of Parenteral and Enteral Nutrition, 35(4), 449-458, 2011
  • Integrating Complimentary and Alternative Medicine in Form of Active Hexose Correlated Compound (AHCC) in the Management of Head & Neck Cancer Patients
    Dillip Kumar Parida (North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences, India), et al.
    International Journal of Clinical Medicine, 2, 588-592, 2011
  • Diet and prostate cancer - a holistic approach to management
    Philippa Cheetham, Aaron E Katz (Columbia University Medical Center, USA)
    Archivos Espanoles de Urologia, 64(8), 720-735, 2011
  • Evaluation of active hexose correlated compound (AHCC) in combination with pegylated liposomal doxorubicin for treatment of ovarian cancer
    Rodney J. Hunter, Judith A. Smith (The University of Texas M.D. Anderson Cancer Center, USA), et al.
    The International Journal of Applied Research, 4(3), 6-14, 2011
  • Active Hexose Correlated Compound (AHCC) and Immune Outcomes in Humans: A Review
    Barry W. Ritz (Department of Biology, Drexel University, USA), et al.
    Natural Medicine Journal, 3(1), 3-7, 2011
  • Genotoxicity and subchronic toxicity evaluation of Active Hexose Correlated Compound (AHCC)
    A. Roberts (Cantox Health Sciences International, Canada), et al.
    Regulatory Toxicology and Pharmacology, 2010
  • Effects of active hexose correlated compound on frequency of CD4+ and CD8+ T cells producing interferon-γ and/or tumor necrosis factor-α in healthy adults
    Thomas Walshe (Brigham and Women's Hospital and Harvard Medical School, USA), et al.
    Human Immunology, 71, 1187-1190, 2010
  • Dietary Administration of Mushroom Mycelium Extracts in Patients with Early Stage Prostate Cancers Managed Expectantly: A Phase II Study
    Yoshiteru Sumiyoshi, Katsuyoshi Hashine (Department of Urology, Shikoku Cancer Center), et al.
    Japanese Journal of Clinical Oncology, 40(10), 967-972, 2010
  • Review of Cancer Therapy with AHCC(R) and GCP(R); The Long-Term Follow-Up over 12 Years for Stage IV (M1) Cancer of the Lung and the Breast
    Reiki Ishizuka, Kuniyoshi Tajima (Tajima Clinic, Japan), Hajime Fujii, Takehito Miura, Yukiko Fukuchi (Amino Up Chemical Co., Ltd., Japan)
    International Journal of Integrative Medicine, 2(1): 98-111 (2010)
  • Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate cancer
    Jeffrey Turner (Medical University of South Carolina, USA)
    Anti-Cancer Drugs, 20(3), 215-216, 2009
  • Retrospective Study in Breast Cancer Patients Supplemented with AHCC
    Yoichi Matsui, Yasuo Kamiyama (First Department of Surgery, Kansai Medical University, Japan)
    International Journal of Integrative Oncology, 3(2), 12-16, 2009
  • Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice
    Kota Shigama, Akihiro Nakaya, Koji Wakame, Hiroshi Nishioka, Hajime Fujii (Amino Up Chemical Co., Ltd., Japan)
    Journal of Experimental Therapeutics and Oncology, 8(1), 43-51, 2009
  • The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents
    Okezie I. Aruoma (Department of Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, USA), Buxiang Sun, Koji Wakame, Eri Sato, Hiroshi Nishioka, Hajime Fujii (Amino Up Chemical Co., Ltd., Japan)
    Cancer Epidemiology, 33, 293-299, 2009
  • Improved Survival of Patients with Gastric Cancer or Colon Cancer when treated with Active Hexose Correlated Compound (AHCC): Effect of AHCC on digestive system cancer
    Yusai Kawaguchi (Department of Surgery, Kansai Medical University, Japan)
    Natural Medicine Journal, 1(1), 2009
  • Low-dose supplementation with active hexose correlated compoundimproves the immune response to acute influenza infection in C57BL/6 mice
    Shoko Nogusa, Jeffrey Gerbino, Barry W. Ritz (Department of Biology, Drexel University, USA)
    Nutrition Research, 29, 139-143, 2009
  • Oral Administration of Active Hexose Correlated Compound Enhances Host Resistance to West Nile Encephalitis in Mice
    Shuhui Wang (Department of Microbiology, Colorado State University, USA)
    The Journal of Nutrition Nutritional Immunology, 139, 598-602, 2009
  • Supplementation with active hexose correlated compound increases survival following infectious challenge in mice
    Barry W. Ritz (Depertment of Bioscience and Biotechnology, Drexel University, USA)
    Nutrition Review, Vol.66, No.9, 526-531, 2008
  • Immunological Effect of Active Hexose Correlated Compound (AHCC) in Healthy Volunteers: A Double-Blind, Placebo-Controlled Trial
    Naoyoshi Terakawa, Yoichi Matsui, Sohei Satoi, Hiroaki Yanagimoto, Kanji Takahashi, Tomohisa Yamamoto, Jun Yamano Soichiro Takai, A-Hon Kwon, Yasuo Kamiyama (Department of Surgery, Kansai Medical University, Osaka, Japan)
    Nutrition and Cancer, Vol.60, No.5, 643-651, 2008
  • Evaluation of Active Hexose Correlated Compound Hepatic Metabolism and Potential for Drug Interactions with Chemotherapy Agents
    Claire M. Mach, PharmD, Judith Smith, PharmD (The University of Texas M. D. Anderson Cancer Center), Hajime Fujii, Phd, Koji Wakame, PhD (Amino Up Chemical Co. Ltd.)
    J. Society for Integrative Oncology Vol.6, No.3, 105-109, 2008
  • Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection
    Hernan Aviles, M.D., Ph.D., Phyllis O'Donnell, Ph.D., Julia Orshal, B.S., Hajime Fujii, Ph.D., Buxiang Sun, M.D., Ph.D., Gerald Sonnenfeld, Ph.D.
    The American Journal of Surgery, 195(4): 537-545 (2008)
  • Natural antisense transcript stabilizes inducible nitric oxide synthase messenger RNA in rat hepatocytes
    Matsui K, Nishizawa M, Ozaki T, Kimura T, Hashimoto I, Yamada M, Kaibori M, Kamiyama Y, Ito S, Okumura T.(Department of Surgery, Kansai Medical University, Moriguchi, Osaka, Japan.)
    HEPATOLOGY, 47(2): 686-697 (2008)
  • A Phase I Study of the Safety of the Nutritional Supplement, Active Hexose Correlated Compound, AHCC, in Healthy Volunteers
    Egilius L. H. Spierings (Medvadis Research Corporation, Wellesley Hills, Massachusetts, USA, Harvard Medical Achool, Boston, Massachusetts, USA
    Journal of Nutritional Science and Vitaminology, 53(6): 536-539 (2007)
  • Effect of AHCC on the Production of Nitric Oxide in Hepatocytes
    Kosuke Matsui, Tadayoshi Okumura (Department of Surgery and the Department of Medical Chemistry, Kansai Medical University, Moriguchi)
    Journal of Parenteral and Enteral Nutrition, 31(5): 373-381 (2007)
  • The influence of AHCC on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice
    Aya Hirose(Amino Up Chemical), Okezie I..Aruoma(Department of Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, Harlem Campus)
    Toxicology and Applied Pharmacology (2007)
  • AHCC Acts as a Prebiotic and Is Antiinflammatory in Rats with Hapten-Induced Colits
    Abdelali Daddaoua,Olga Martinez-Augustin (Department of Biochemistry and Molecular Biology)
    The Journal of Nutrition, 137(5): 1222-1228 (2007)
  • Nutritional Food Active Hexose Correlated Compound (AHCC) Enhances Resistance against Bird Flu
    Hajime Fujii (Amino Up Chemical Co., Ltd.), et al.
    Japanese Journal of Cmprementary and Alternative Medicine, 4(1): 37-40 (2007)
  • The Effects of GAC on the Biochemical Profiles and Quality of Life of Metastatic Prostate Cancer Patients
    Sung Joon Hong, Sun Buxiang
    The Korean Journal of Urology Vol.47 No.5 (2006)
  • AHCC Enhances Resistance to Infection in a Mouse Model of Surgical Wound Infection
    HERNAN AVILES, GERALD SONNENFELD
    SURGICAL INFECTIONS Vol.7 No.6 (2006)
  • Supplementation with Active Hexose Correlated Compound Increases the Innate Immune Response of Young Mice to Primary Influenza Infection
    Barry W. Ritz, Shoko Nogusa,Elizabeth M. Gardner
    The Journal of Nutrition Nutritional Immunology (2006)
  • Prognostic Improvement of Patients with Advanced Liver Cancer after AHCC Treatment Suwanna Cowawintaweewat, Suphon Manoromana, Wanpen Chaicumpa
    Asian Pacific Journal of Allergy and Immunology, 24(1): 33-45 (2006)
  • Active Hexose Correlated Enhances Tumor Surveillance Through Regulating Both Innate And Adaptive Immune Responses
    Yunfei Gao, Dongqing Zhang, Buxiang Sun, Hajime Fujii,Zhinan Yin(Shanghai Institute of Immunology, Shanghai Jiaotong University、Amino Up Chemical Co., Ltd. )
    Cancer Immunology, Immunotherapy, 55(10): 1258-1266 (2006)
  • Nationwide Survey on Complementary and Alternative Medicine in Cancer Patients in Japan
    Ichinosuke Hyodo, Shigemitsu Takashima
    Journal of Clinical Oncology, 23(12): 2645-2654 (2005)
  • An In-Office Evaluation of Four Dietary Supplements on Natural Killer Cell Activity
    James Belanger(Lexington Natural Health Center)
    Townsend Letter for Doctors and Patients,Feb-March,88-92(2005)
  • Use of Animal Models for Space Flight Physiology Studies, with Special Focus on the Immune System
    Gerald Sonnenfeld(Department of Biological Sciences, Binghamton University)
    Gravitational and Space Biology, 18(2): 31-35 (2005)
  • Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions
    Gerald Sonnenfeld (Morehouse School of Medicine)
    Journal of Applied Physiology, 97(4): 1437-1444 (2004)
  • Amerioration by AHCC of Endocrine Disturbances Induced by Oxidative Stress in the Rat
    She-Fang Ye (Dokkyo Univ.) et al.
    Endocrine Regulations, 38:7-13 (2004)
  • AHCC Provides Survival Advantage for Advanced Cancer Patients
    Jang Seok Won( Seoul Internal Medicine Clinic, Cancer Diagnostic Center)
    Biotherapy,Vol17, No5, 463-465 (2003)
  • Suppressive effects of AHCC on the increased activity of hepatic and renal ornithine decarboxylase induced by oxidative stress
    She-Fang Ye (Dokkyo Univ.) et al.
    Life Science, 74:593-602 (2003)
  • Clinical outcome of curative liver resections using a microwave tissue coagulator for primary hepatocellular carcinoma
    Yasuo Kamiyama (Kansai Medical University), et al.
    Journal of Microwave Surgery, 21:53-56 (2003)
  • AHCC enhances resistance to Klebsiella pneumniae infection in mice in the hindlinb-unloading model of spaceflight conditions
    Gerald Sonnenfeld (Morehouse School of Medicine)
    J Appl Physiol. 95(2),491-496 Aug (2003)
  • Prophylactic Efficacy of a Basidiomycetes Preparation AHCC against Lethal Candida albicans Infection in Experimental Granulocytopenic Mice
    Shigeru Abe (Teikyo University School of Medicine), et al.
    Japanese Journal of Medical Mycology, 44(2):127-131 (2003)
  • H-2 haplotype-dependent serum IL-12 production in tumor-bearing mice treated with various mycelial extracts
    Akikuni Yagita, Yasushi Sukegawa (Kinki University, Japan), et al.
    In Vivo, 16: 49-54 (2002)
  • Effects of a mushroom mycelium extract on the treatment of prostate cancer
    Ralph W.deVere White(UC Davis), et al.
    ADULT UROLOGY, 60: 160-164 (2002)
  • Improved prognosis of postoperative hepatocellular carcinoma patients treated with functional foods
    Yoichi Matsui (Kansai Medical University), et al.
    Journal of Hepatology, 37, 78-86 (2002)
  • Preventive Effects of Active Hexose Correlated Compound (AHCC) on Oxidative Stress Induced by Ferric Nitrilotriacetate in the Rat
    Shuyi Wang (Dokkyo University School of Medicine), et al.
    Dokkyo J. Med. Sci., 28(2), 745-752 (2001)
  • Beneficial Effects of Active Hexose Correlated Compound (AHCC) on Immobilization Stress in the Rat
    Shuyi Wang (Dokkyo University School of Medicine), et al.
    Dokkyo J. Med. Sci., 28(1), 559-565 (2001)
  • The use of mushroom glucans and proteoglycans in cancer treatment
    Parris M. Kidd (University of California at Berkeley, USA)
    Alternative Medicine Review, 5(1): 4-27 (2000)
  • Reversing Immunosenescence: The Key To Anti-Aging
    Fred Pescatore, MD, MPH
    International Journal of Anti-Aging Medicine, Winter 2000, 47-49 (2000)
  • Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in the rat
    R. Burikhanov (Dokkyo Univ.) et al.
    Endocrine Regulations, 34: 181-188 (2000)
  • Prophylactic Efficacy of a Basidiomycetes Preparation AHCC against Lethal Opportunistic Infections in Mice
    Hiroko Ishibashi (Teikyo University School of Medicine), et al.
    YAKUGAKU ZASSHI, 120: 749-753 (2000)
  • Protective Effects of Active Hexose Correlated Compound (AHCC) on the Onset of Diabetes Induced by Streptozotocin in the Rat
    Koji Wakame (Amino Up Chemical Co., Ltd.)
    Biomedical Research, 20(3): 145-152 (1999)
  • Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma
    Kazuhiro Matsusita (School of Medicine, Hokkaido University), et al.
    Anti-Cancer Drugs 9: 343-350 (1998)